Clinical trials
Anemia, Refractory, with Excess of Blasts trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2024 | 1 |
| 2025 | 6 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 9 |
| Active, not recruiting | 1 |
| Completed | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The First Affiliated Hospital of Soochow University | 2 |
| Chaser Therapeutics, Inc. | 1 |
| Cullgen (Shanghai),Inc | 1 |
| First Affiliated Hospital of Zhejiang University | 1 |
| Fujian Medical University Union Hospital | 1 |
| Institute of Hematology & Blood Diseases Hospital, China | 1 |
| Liping Dou | 1 |
| Novartis Pharmaceuticals | 1 |
| Ruijin Hospital | 1 |
| Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia, Refractory, with Excess of Blasts | 11 |
| Leukemia, Myeloid, Acute | 9 |
| Myelodysplastic Syndromes | 2 |
| Anemia, Aplastic | 1 |
| Cytopenia | 1 |
| Hematologic Diseases | 1 |
| Leukemia | 1 |
| Leukemia, Myelomonocytic, Chronic | 1 |
| Recurrence | 1 |
| Sarcoma, Myeloid | 1 |
Trials
Showing 51 to 11 of 11. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.